Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance. - Wikidata - awgldk - TriplyDB

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

http://www.wikidata.org/entity/Q36050687

about

Targeting folate receptor alpha for cancer treatment Profile of farletuzumab and its potential in the treatment of solid tumors A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer Farletuzumab in lung cancer Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resection.Blood-based Tumor Markers in Lung Cancer Folate receptor-targeted ultrasonic PFOB nanoparticles: Synthesis, characterization and application in tumor-targeted imaging.Differential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potential One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.Folate receptor alpha, mesothelin and megakaryocyte potentiating factor as potential serum markers of chronic kidney disease.Rapid and Selective Determination of Folate Receptor α with Sensitive Resonance Rayleigh Scattering Signal.Intraoperative Molecular Imaging of Lung Adenocarcinoma Can Identify Residual Tumor Cells at the Surgical Margins Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma.Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR.Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application Multi-Modal Imaging in a Mouse Model of Orthotopic Lung Cancer Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging.A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity.A preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer.Expression of high affinity folate receptor in breast cancer brain metastasis.Targeting Nonsquamous Nonsmall Cell Lung Cancer via the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]Pyrimidine Thienoyl Antifolates.Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4.Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed.Detection of circulating tumor cells in non-small cell lung cancer.ATPase inhibitory factor 1 expression is an independent prognostic factor in non-small cell lung cancer Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease.Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients.Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome.Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17 The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis.Intraoperative molecular imaging to identify lung adenocarcinomas.The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity.Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry.

P2860

Q26744215-B62B5B05-0F00-4239-B573-40330BF0D4EF Q26750431-D0E8CE7C-2355-4982-8537-ABEBA9676A8A Q26781856-DAF36FEC-ED74-4F77-B509-DFB08E320824 Q26997008-66CDB17E-ECFC-4960-A2E8-FEBE398B6FC9 Q27308955-4C79D047-A28B-4790-9DAC-20E0D9B59696 Q28072736-7FE81375-F046-4AF0-8687-71627023BED4 Q30356285-C6C1F299-19D1-4D95-961D-0B0DCCFF74D2 Q33618570-7241CD19-0653-424E-B66E-685860FE5E12 Q33618935-1D3D6C41-36F1-4C4A-96E8-12EA8F024B2A Q33734661-74C1DC15-7434-4B32-80FD-4701E503FB01 Q33775377-57971C30-A011-488E-A9E8-08D7219D82FD Q33808756-32B70DA3-22BF-449A-B4AC-3D09EF699C02 Q33824400-E70E2746-13CB-4FF2-B6C4-89CB17FC0320 Q33914066-66634B50-C95B-4B60-B637-6BA2B984B552 Q35063733-28033185-EB82-46DF-A030-D82D26A3842A Q35793909-0A5BE840-CA25-4375-A058-9CFC0E8FD276 Q35854305-BE34650E-31E0-4FB5-97AF-9FA697EE87E0 Q35915267-5DD38B3B-7A86-489E-A0E9-08DA7AC24171 Q35942615-8A6FEDC1-F4A6-424F-A58C-D74908B4638E Q36119987-DAAC2ABA-52A2-46D0-8F35-79679397AD65 Q36146218-B11504BC-A391-4D00-B5A7-ADBD76FC6EFC Q36356392-E3A04AA3-74EF-48A3-B382-87D8A4B64130 Q36430673-A4862A99-C4FF-4259-A811-3201CE5A0A1E Q36557588-23793145-29F0-47B5-81DA-956B011D48B4 Q36733474-C2E76698-6A1D-4283-8A13-DB216AA4A218 Q36808757-429A0D1F-0761-4406-A853-A63D2B667B5A Q36821156-742474BA-50B8-47EB-ADC1-1335DB5B7806 Q36948886-3FB99DC6-893A-47E8-9F47-009031DB0841 Q36958409-6AEB2925-E75E-4ADD-8D75-6F920F526067 Q37052124-89B33BD7-D242-4C18-A663-C7E0BA952F89 Q37075319-94E11E85-88C9-4D61-814C-A0D61D96D40A Q37109499-4F74C72E-6980-40FB-9350-78CAD74C8188 Q37190264-D6085B23-DB4F-4112-8F8C-DF03F77209EF Q37362630-93CDEAC0-D6D1-4403-A2FB-BAA40B1A1889 Q37381637-7CA47E46-5B04-4ABF-BCF2-8404B9354148 Q37528105-9FA94646-FFFB-47F1-9007-5E940A10BC64 Q37586901-BE063D2C-A2BB-4891-B40B-1195EB134C90 Q37604323-973550CA-8A2A-4624-836E-70E94E0F9217 Q37641578-D3497105-271E-4179-80A5-A19987AA647D Q37710444-0E82980F-E3BB-4068-A6DF-C49D41F5B0B9

P2860

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

http://www.wikidata.org/entity/Q36050687

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

@ast

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

@en

type

label

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

@ast

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

@en

prefLabel

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

@ast

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

@en

P1433

Q36050687-7EA4A266-F858-4A16-87BC-E46DCAD1A3AC

P1476

Q36050687-92AC5AB1-A344-4298-AA54-20A5C75886C6

P2093

Q36050687-69ABF79B-42DD-4924-B025-C41D886560F7

Q36050687-6D31B70D-8789-4656-AAB1-D7BBDB7910F9

Q36050687-84979382-E42E-4E7C-9FF8-200043964D5A

Q36050687-9951AF8D-0B72-448D-8A46-F11784492B73

Q36050687-BEE6E5AC-EA05-47CF-9E4D-719E5FB4F62F

Q36050687-BFF0D9B9-2EA1-428E-A286-18128B0E1D8A

Q36050687-D1148D2E-2926-4009-94D7-1749F7640DAA

Q36050687-D27DFFBA-B9F4-449D-A2DE-B5AE5679350B

P2860

Q36050687-1C52C1C6-DB44-4CC3-93B2-5D43E0D4AE19

Q36050687-282CF6D8-91E0-43C7-A26E-8B2FD2EF938C

Q36050687-2CF218F8-E46A-4BFA-BABE-D1C51634F5D9

Q36050687-2DA612D4-3826-4D7A-A63D-C3DFB4BF76F5

Q36050687-5044F57D-C106-4FB3-AA82-14326C82BF28

Q36050687-54C059B5-0892-4293-B555-9F2D2630B937

Q36050687-6C862F27-5927-4639-B542-4C69B4420E91

Q36050687-731F72D5-6ACA-4178-B348-676D8A8749BA

Q36050687-7ADF9F16-F244-4B85-A768-E8A96658224E

Q36050687-7D46E8D8-D6D7-400A-93E6-CBD44E62A335

P304

Q36050687-690185F5-3F2D-4D1C-A42A-3F0CE90D6023

P31

Q36050687-BF106393-03CC-4EB8-A7D8-F918FBE7781C

P356

Q36050687-4759CDBF-29BF-41A2-81D1-BAE8F56EDED1

P407

Q36050687-FC9E882D-CFAE-4942-8BFA-D83971AC9176

P433

Q36050687-E1F96101-3B65-4EAC-B134-0D5E08DD4BDE

P478

Q36050687-9EF035FE-6DFB-4345-815E-D9B875ABD61A

P577

Q36050687-4DCB0EB9-304C-4894-8D48-B8462F04337B

P698

Q36050687-D3F14ECD-ED18-459D-8003-0DAADBF12E86

P932

Q36050687-A49801D5-7B7A-44E2-9C23-12B1F907E1F5

P356

P1433

P1476

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

@en

P2093

Anil Vachani

http://www.w3.org/2001/XMLSchema#string

Daniel J O'Shannessy

http://www.w3.org/2001/XMLSchema#string

Elizabeth B Somers

http://www.w3.org/2001/XMLSchema#string

Gordon Yu

http://www.w3.org/2001/XMLSchema#string

Robert P Thiel

http://www.w3.org/2001/XMLSchema#string

Robert Smale

http://www.w3.org/2001/XMLSchema#string

Sunil Singhal

http://www.w3.org/2001/XMLSchema#string

Yao-Shi Fu

http://www.w3.org/2001/XMLSchema#string

P2860

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

Functional folate receptor alpha is elevated in the blood of ovarian cancer patients.

Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.

EC-145, a folate-targeted Vinca alkaloid conjugate for the potential treatment of folate receptor-expressing cancers.

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

Overexpression of folate binding protein in ovarian cancers.

Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.

Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer.

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.

P304

414-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.489

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22547449

http://www.w3.org/2001/XMLSchema#string

P932

3380576

http://www.w3.org/2001/XMLSchema#string